.Attribute Medication, Posted online: 03 September 2024 doi:10.1038/ s41591-024-03223-zThis Point of view requires addition of clients with MASLD and measurement of liver outcomes in cardio-- renal-- metabolic tests, when information suggest mechanistically probable advantages and also professional safety and security-- and also details considerations for test concept and also regulatory commendation.